FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns a method for reducing individual's blood glucose concentration after meals, comprising administering to said individual an effective amount of a combination of peptides derived from sea fish, and nucleotides recovered from fish milt, wherein said combination is administered to an individual before or during meals; wherein peptides isolated from sea fish and nucleotides recovered from fish milt are present in ratio from 2:1 to 10:1 of total weight of said combination; wherein peptides isolated from sea fish are obtained by enzymatic hydrolysis. Group of inventions also relates to a composition containing peptides isolated from sea fish and nucleotides recovered from fish milt at ratio of 10:1 (weight/weight) relative to total weight.
EFFECT: group of inventions provides reduction of blood glucose level of an individual.
14 cl, 1 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW DERIVATIVES OF OXYNTOMODULIN AND PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY | 2012 |
|
RU2612906C2 |
| PREPARATION FOR ASPARTATE APPLICATION FOR BLOOD GLUCOSE LEVELS CONTROL | 2005 |
|
RU2402243C2 |
| FOOD ADDITIVE AND COMPOSITION FOR TREATING METABOLIC SYNDROME | 2016 |
|
RU2741637C2 |
| CONJUGATE, CONTAINING OXYNTOMODULIN AND FRAGMENT OF IMMUNOGLOBULIN, AND USE THEREOF | 2012 |
|
RU2607365C2 |
| COMBINATION OF LEUCINE SOURCE AND OMEGA-3 UNSATURATED FATTY ACID SOURCE FOR TREATING HYPERCALCEMIA | 2010 |
|
RU2555359C2 |
| NUTRITIVE COMPOSITION FOR MAMMAL IMMUNE SYSTEM IMPROVEMENT | 2009 |
|
RU2525429C2 |
| DEVICES FOR BLOOD INTAKE, CONTAINING LYSOPHOSPHOLIPASE INHIBITOR | 2012 |
|
RU2623049C2 |
| COMPOSITIONS FOR DRUG INTRODUCTION | 2009 |
|
RU2554814C2 |
| NEW VERSION OF EXENDIN OR ITS CONJUGATE | 2010 |
|
RU2528734C2 |
| FORMULA FOR INTRODUCING RNA | 2019 |
|
RU2797147C2 |
